Sleeping Habits on Performance Following Sleep Deprivation

Sponsor
University of Guelph (Other)
Overall Status
Recruiting
CT.gov ID
NCT05942664
Collaborator
(none)
20
1
2
5.2
3.9

Study Details

Study Description

Brief Summary

The goal of this randomized crossover clinical trial is to determine if habitual sleeping habits can predict endurance performance following a night of partial sleep deprivation in healthy untrained, recreationally trained, and trained cyclists (18-50 years, ~50% females).

The main questions it aims to answer are:
  1. Can habitual sleeping habits predict, or do different types of sleepers alter, performance outcomes following sleep deprivation?

  2. Does sleep deprivation alter blood pressure, heart rate, or metabolic responses during a 20-minute time trial, and/or are these altered amongst different types of sleepers?

  3. Can habitual sleeping habits predict, or do different types of sleepers alter, flow-mediated dilation following a night of normal sleep and/or sleep deprivation?

  • Participants will be asked to perform 4 performance tests (20-minute time trial), 2 for familiarization, and 2 testing visits (1 under normal sleep and 1 under partial sleep deprivation).

  • For 1 week prior to each testing visit, sleep will be tracked using an ActiGraph device.

  • During each testing visit, and prior to the performance test, the vascular function of the superficial femoral artery will be assessed using a flow-mediated dilation technique.

The investigators hypothesize that habitual early sleepers, poor sleepers, those with greater variability in sleep duration, and females will show the greatest impairments in performance and flow-mediated dilation following partial sleep deprivation.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Sleep
N/A

Detailed Description

Five separate visits will take place. Participants will be asked to abstain from heavy exercise, napping, alcohol, recreational drugs, and acute supplementation or medication use (i.e., melatonin, antihistamines) 24 hours before each visit. The first visit will always be the introductory visit, which will be followed by two familiarization visits. The next two visits will be testing visits and randomized (one normal sleep visit and one sleep deprivation visit).

Introductory visit: Prior to arriving at the lab, participants will read over and sign the consent form, complete the Pittsburgh Sleep Quality Index (PSQI), complete the Morningness-Eveningness Questionnaire (MEQ), complete a general health questionnaire, and complete the PAR-Q+ remotely. After obtaining consent and upon arriving at the lab, height and weight will be measured. This will be followed by a maximal exercise test to assess peak oxygen uptake (VO2peak) on a cycle ergometer. After this, participants will be given a rest period, which will be followed by the completion of a 5-minute time trial so the participant can get familiarized with pushing themselves during the performance test.

Pre-testing: Participants will be equipped with an ActiGraph device to measure sleeping patterns over a 1-week time frame prior to each testing visit as well as the night prior to each familiarization visit. These data will then be used to determine each participant's sleep-wake schedule for the testing visits. Furthermore, the day prior to each familiarization visit and testing visit, participants will be asked to complete a food diary using an online app (MyFitnessPal), which will ask participants to list the ingredients and quantity of each ingredient consumed for each meal and beverage that day, night and subsequent day. Participants will be asked to abstain from food for 4 hours upon arriving at the lab, prior to each familiarization and testing visit.

Familiarization visits: Upon lab arrival, participants will be provided with a standardized snack, which includes instant Quaker oats mixed with water. The amount will be based on body weight (1 gram of carbohydrates per body weight in kilograms). Following this, the participant will complete a 20-minute time trial on a cycle ergometer.

Testing visits: Upon lab arrival, participants will lay supine quietly, and resting hemodynamic measurements (blood pressure and heart rate) will commence. Following this, the researcher will perform a flow-mediated dilation test to assess vascular function of the superficial femoral artery. This will be followed by consuming the same standardized snack as the familiarization visit, and then a 20-minute time trial on a cycle ergometer.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
Flow-mediated dilation analysis will be blinded by the assessor by having a second party rename files to ensure they are unidentifiable.
Primary Purpose:
Diagnostic
Official Title:
Can Habitual Sleeping Habits Predict Performance Outcomes Following Sleep Deprivation?
Actual Study Start Date :
Jun 26, 2023
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Sham Comparator: Normal sleep

Participants will be asked to sleep during their normal sleep times prior to this visit

Behavioral: Sleep
Sleep will be restricted to 60% normal sleep duration

Active Comparator: Sleep deprivation

Participants will be asked to go to bed normally but wake up earlier, such that normal sleep duration is restricted by 60%. For example, if someone normally sleeps for 8 hours by falling asleep at 11 pm and waking up at 7 am, they will be asked to fall asleep normally (11 pm) and sleep for 3.2 hours, which results in a wake-up time of 2:12 am.

Behavioral: Sleep
Sleep will be restricted to 60% normal sleep duration

Outcome Measures

Primary Outcome Measures

  1. Performance [During each familiarization visit and testing visit (4 time points total)]

    Mean power achieved during a 20-minute time trial on a cycle ergometer

Secondary Outcome Measures

  1. Flow-mediated dilation [During both testing visits (2 time points total)]

    Absolute and percent dilation of the superficial femoral artery after 5 minutes of blood flow occlusion

Other Outcome Measures

  1. Resting systolic and diastolic blood pressure [During both testing visits (2 time points total)]

    Resting blood pressure while participant is supine, assessed in 1-minute intervals through an automated oscillometric device and non-invasive, continuous blood pressure (i.e., on a heartbeat-by-beat basis)

  2. Resting heart rate [During both testing visits (2 time points total)]

    resting heart rate while participant is supine, assessed via ECG

  3. Systolic and diastolic blood pressure during exercise [During the introductory visit and during each familiarization visit and testing visit (5 time points total)]

    Blood pressure during the VO2peak test, 12-minute warm up, and performance tests, in 2-minute intervals, assessed using an automated oscillometric device

  4. Heart rate during exercise [During the introductory visit and during each familiarization visit and testing visit (5 time points total)]

    Heart rate during the VO2peak test, 12-minute warm up, and performance tests, on a heartbeat-by-beat basis, assessed using a heart rate monitor

  5. Gross efficiency during exercise [During each familiarization visit and testing visit (4 time points total)]

    Movement efficiency during the 12-minute warm up, prior to the performance tests. This will be calculated using the following formula: (work (J)/energy expenditure (J))*100. Work is calculated as: (watts during the warm up * time) and energy production is determined by the metabolic cart, and will be further broken down into joules by multiplying energy expenditure in kcals by 4184.

  6. Oxygen uptake during exercise [During the introductory visit and during each familiarization visit and testing visit (5 time points total)]

    Oxygen uptake during the VO2peak test, 12-minute warm up, and performance tests, assessed on a breath-by-breath basis using a metabolic cart

  7. Carbon dioxide production during exercise [During the introductory visit and during each familiarization visit and testing visit (5 time points total)]

    Carbon dioxide production during the VO2peak test, 12-minute warm up, and performance tests, assessed on a breath-by-breath basis using a metabolic cart

  8. Systolic and diastolic blood pressure during recovery [During each familiarization visit and testing visit (4 time points total)]

    Three minutes of recovery blood pressure following the performance tests, in 1-minute intervals

  9. Heart rate during recovery [During each familiarization visit and testing visit (4 time points total)]

    Three minutes of heart rate following the performance tests, on a heartbeat-by-beat basis, assessed using a heart rate monitor

  10. Oxygen uptake during recovery [During each familiarization visit and testing visit (4 time points total)]

    Three minutes of oxygen uptake following the performance tests, assessed breath-by-breath, using a metabolic cart

  11. Carbon dioxide production during recovery [During each familiarization visit and testing visit (4 time points total)]

    Three minutes of carbon dioxide production following the performance tests, assessed breath-by-breath, using a metabolic cart

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Ages 18-50 years

  • Free of known cardiovascular or metabolic diseases or sleep disorders

  • No history of smoking (within the past 3 months)

  • Able to engage in physical activity assessed through the physical activity readiness questionnaire (PAR-Q+) (answer no to all questions

  • No prescription of chronic medications other than oral contraceptives

  • Able to abide by sleep protocols for all visits

  • Individuals who are not allergic to ultrasound gel

  • Individuals who are able to consume the ingredients of instant oatmeal (whole grain oats, sugar, salt, and natural flavour)

  • Individuals who are not pregnant

Exclusion Criteria:
  • Ages <18 years, >50

  • Individuals diagnosed with cardiovascular or metabolic disease or sleep disorders

  • Has a history of smoking (within the past 3 months)

  • Not ready to engage in physical activity (answer yes to one or more questions in PAR-Q+)

  • Individuals with prescription of chronic medications other than oral contraceptives

  • Unable to abide by sleep protocols for any testing visit

  • Allergic to ultrasound gel

  • Individuals who are unable to consume the ingredients of instant oatmeal (whole grain oats, sugar, salt, and natural flavour)

  • Pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Guelph - Human Cardiovascular Physiology Laboratory Guelph Ontario Canada N1G2W1

Sponsors and Collaborators

  • University of Guelph

Investigators

  • Principal Investigator: Philip Millar, University of Guelph

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Philip Millar, Associate Professor, University of Guelph
ClinicalTrials.gov Identifier:
NCT05942664
Other Study ID Numbers:
  • 23-01-019
First Posted:
Jul 12, 2023
Last Update Posted:
Jul 12, 2023
Last Verified:
Jul 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Philip Millar, Associate Professor, University of Guelph
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 12, 2023